IMR OpenIR

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
Authors:  Zeng, Guoming;  Jin, Libo;  Ying, Qinsi;  Chen, Haojie;  Thembinkosi, Murinda Charmaine;  Yang, Chunguang;  Zhao, Jinlong;  Ji, Hao;  Lin, Sue;  Peng, Renyi;  Zhang, Maolan;  Sun, Da
Favorite  |  View/Download:30/0  |  Submit date:2021/02/02
cancer immunotherapy  Treg cells  FoxP3  targeting Treg cells  anti-cancer  
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
Authors:  Zeng, Guoming;  Jin, Libo;  Ying, Qinsi;  Chen, Haojie;  Thembinkosi, Murinda Charmaine;  Yang, Chunguang;  Zhao, Jinlong;  Ji, Hao;  Lin, Sue;  Peng, Renyi;  Zhang, Maolan;  Sun, Da
Favorite  |  View/Download:31/0  |  Submit date:2021/02/02
cancer immunotherapy  Treg cells  FoxP3  targeting Treg cells  anti-cancer  
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
Authors:  Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye;  Zhao YanFang;  Gong Ping
Favorite  |  View/Download:47/0  |  Submit date:2021/02/02
TYROSINE KINASE INHIBITOR  LUNG-CANCER  RECEPTOR  T790M  MUTANT  MUTATION  Aminopyrimidines  EGFR T790M/L858R  Selectivity  Anti-resistance  Antiproliferative activity  
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
Authors:  Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye;  Zhao YanFang;  Gong Ping
Favorite  |  View/Download:49/0  |  Submit date:2021/02/02
TYROSINE KINASE INHIBITOR  LUNG-CANCER  RECEPTOR  T790M  MUTANT  MUTATION  Aminopyrimidines  EGFR T790M/L858R  Selectivity  Anti-resistance  Antiproliferative activity